Experimental Ebola
-
{
- All
- News
-
Thousands of Liberians in 'Post-Ebola Syndrome' Study
- Thursday June 18, 2015
- World News | Agence France-Presse
Liberia launched a five-year study on Wednesday to unravel the mystery of the long-term health effects that plague Ebola survivors and assess how long they should go without sex.
-
www.ndtv.com
-
WHO Sees Small-Scale Use of Experimental Ebola Vaccines in January
- Saturday September 27, 2014
- World News | Reuters
The World Health Organisation (WHO) said on Friday it expected to begin small-scale use of two experimental Ebola vaccines in West Africa early next year and in the meantime transfusions of survivors' blood may offer the best hope of treatment.
-
www.ndtv.com
-
WHO Backs Use of Experimental Ebola Drugs in West Africa
- Wednesday August 13, 2014
- World News | Reuters
People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.
-
www.ndtv.com
-
Thousands of Liberians in 'Post-Ebola Syndrome' Study
- Thursday June 18, 2015
- World News | Agence France-Presse
Liberia launched a five-year study on Wednesday to unravel the mystery of the long-term health effects that plague Ebola survivors and assess how long they should go without sex.
-
www.ndtv.com
-
WHO Sees Small-Scale Use of Experimental Ebola Vaccines in January
- Saturday September 27, 2014
- World News | Reuters
The World Health Organisation (WHO) said on Friday it expected to begin small-scale use of two experimental Ebola vaccines in West Africa early next year and in the meantime transfusions of survivors' blood may offer the best hope of treatment.
-
www.ndtv.com
-
WHO Backs Use of Experimental Ebola Drugs in West Africa
- Wednesday August 13, 2014
- World News | Reuters
People infected in the West African Ebola outbreak can be offered untested drugs, the World Health Organisation said on Tuesday, but the scarcity of supplies has raised questions about who gets priority access to treatment.
-
www.ndtv.com